[Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].

@article{Zierhut2001ImmunosuppressiveTW,
  title={[Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].},
  author={Manfred Zierhut and Nicole Stuebiger and W. Aboalchamat and Herwig Landenberger and Alexander Arthur Bialasiewicz and Katrin Engelmann},
  journal={Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft},
  year={2001},
  volume={98 7},
  pages={647-51}
}
BACKGROUND Severe forms of uveitis can often only be managed sufficiently with systemic immunosuppression. All available drugs are known for their relative high rate of side-effects. Mycophenolate mofetil (MMF), an immunosuppressant successfully used in management after organ transplantation and many autoimmune diseases, has shown remarkably less side-effects when used for various forms of uveitis in monotherapy or in combination with corticosteroids. The aim of this multicenter-study was to… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…